High-Dose-Rate Brachytherapy of a Single Implant With Two Fractions Combined With External Beam Radiotherapy for Hormone-Naive Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 4, 2008, Pages 1002-1009

  Sato, Morio ^a   Mori, Takashi ^a   Shirai, Shintaro ^a   Kishi, Kazushi ^a   Inagaki, Takeshi ^a   Hara, Isao ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Brachytherapy; High dose rate; Prostate cancer; Radiation therapy; Radiation toxicity

Indexed keywords

ONCOLOGY; RADIOTHERAPY; TERMINOLOGY; TUMORS;

BRACHYTHERAPY; HIGH-DOSE-RATE; PROSTATE CANCER; RADIATION THERAPY; RADIATION TOXICITY;

TOXICITY;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER SURVIVAL; CHEMICAL ANALYSIS; CONTROLLED STUDY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NEPHROTOXICITY; PENIS ERECTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 54049137994     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.02.055     Document Type: Article

References (33)

1. Stromberg J., Martinez A., Gonzalez J., et al. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 33 (1995) 161-171
2. Martinez A.A., Gustafson G., Gonzalez J., et al. Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 316-327
3. Mate T.M., Gottesman J.E., Hatton J., et al. High dose-rate afterloading iridium-192 prostate brachytherapy: Feasibility report. Int J Radiat Oncol Biol Phys 41 (1998) 525-533
4. Yoshioka Y., Nose T., Yoshida K., et al. High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 48 (2000) 675-681
5. Hiratsuka J., Jo Y., Yoshida K., et al. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Int J Radiat Oncol Biol Phys 59 (2004) 684-690
6. Akimoto T., Katoh H., Noda S., et al. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genito urinary toxicity. Int J Radiat Oncol Biol Phys 63 (2005) 472-478
7. Fowler J.F. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 44 (2005) 2656-276
8. Ishikawa H., Sato M., Shirai S., et al. Interfractional fluctuation of rectal dose in high dose rate brachytherapy for prostate cancer. Radiat Med 24 (2006) 610-616
9. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
10. Roach M., Hanks G., Thames H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
11. Elgamal A.A., Van Poppel H.P., Van de Voorde W.M., et al. Impalpable invisible stage T1c prostate cancer: Characteristics and clinical relevance in 100 radical prostatectomy specimens-A different view. J Urol 157 (1997) 244-250
12. Pound C.R., Partin A.W., Epstein J.I., et al. Prostate specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am 24 (1997) 395-406
13. Zincle H., Oesterling J.E., Blute M.L., et al. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 152 (1994) 1850-1857
14. Han M., Partin A.W., Poung C.R., et al. Long-team biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28 (2001) 555-565
15. Hull G.W., Rabbani F., Abbas F., et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167 (2002) 528-534
16. Eulae S.M., Van Hollebeke L., Cavanagh W., et al. High dose rate iridium 192 brachytherapy in localized prostate cancer: Results and toxicity with maximum follow-up of 10 years. [abstract]. Int J Radiat Oncol Biol Phys 52 (2002) 81-90
17. Galalae R.M., Martinez A.A., Mate T., et al. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1048-1055
18. Demanes D.J., Rodriguez R.R., Schour L., et al. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California Endocurietherapy's 10 year results. Int J Radiat Oncol Biol Phys 61 (2005) 1306-1316
19. 192Ir source, and neoadjuvant hormonal manipulation for prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 38-47
20. Hodgson D., Warde P., and Gospodarowicz M. The management of locally advanced prostate cancer. Urol Oncol 4 (1998) 3-12
21. Fallon B., and Williams R.D. Current options in the management of clinical stage C prostatic carcinoma. Urol Clin North Am 17 (1990) 853-866
22. van den Ouden D., Hop W.C., and Schroder F.H. Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy. J Urol 160 (1998) 1392-1397
23. Vargas C.E., Martinez A.A., Boike T.P., et al. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: Results of a phase I to II study. Int J Radiat Oncol Biol Phys 66 (2006) 416-423
24. Bolla M., Collette L., Blank L., et al. Long-team results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomized trial. Lancet 360 (2002) 103-106
25. Perlmutter M.A., and Lepor H. Androgen deprivation therapy in the treatment of advanced prostate cancer. Rev Urol 9 (2007) 3-8
26. Martinez A., Galalae R., Gonzalez J., et al. No apparent benefit at 5 years from a course of neoadjuvant/concurrent androgen deprivation for patients with prostate cancer treated with a high total radiation dose. J Urol 170 (2003) 2296-2301
27. Grills I.S., Martinez A.A., Hollander M., et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 171 (2004) 1098-1104
28. Zelefsky M.J., Wallner K.E., Ling C.C., et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 17 (1999) 517-522
29. Terk M.D., Stock R.G., and Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of prostate. J Urol 160 (1998) 1379-1382
30. Egawa S., Shimura S., Irie A., et al. Toxicity and health-related quality of life during and after high dose rate brachytherapy followed by external beam radiotherapy for prostate cancer. Jpn J Clin Oncol 31 (2001) 541-547
31. Galalae R.M., Kovacs G., Schultze J., et al. Long-team outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 81-90
32. Kitano M., Ishiyama H., Niibe J., et al. High dose rate brachytherapy with external beam radiation therapy for localized prostate cancer. Jpn Soc Ther Radiol Oncol 17 (2004) 88
33. Zelefsky M.J., Cowen D., Fuks Z., et al. Long-team tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 85 (1999) 2460-2468